NEW YORK ( TheStreet) -- Analysts expect these 10 mid-cap stocks to outperform their peers and broader markets, based on their respective 12-month price targets. These mid caps have an upside potential of 60%-99% with a mean upside value of around 40% and average buy ratings of 73%.

These stocks received analysts' buy ratings of 35%-100% with mean of 65%. We have identified these stocks from Bermuda, China and the U.S., and across diverse sectors such as financials, information technology, telecom, healthcare, industrials, materials, and consumer staples.

10. China Real Estate Information ( CRIC) provides real estate information and consulting services.

At $7.08, the stock is trading at an attractive PE multiple of 17.6, whereas Morning Star ( MORN), CoreLogic ( CLGX), CoStar Group ( CSGP) and ePocrates ( EPOC) have PE multiples of 59.9, 18.3, 57.6 and 22.0, respectively.

The stock received 83% buy ratings from five of the six analysts covering the stock, while one analyst rated a hold.

Data from Bloomberg has analysts forecasting an average price target of $11.3, up 60% from the current level.

9. TiVo ( TIVO) provides subscription-based services that are enabled by a personal video recorder.

Analysts polled by Bloomberg expect the stock to gain an average 60% over the next 12 months, while peers DIRECTV ( DTV), Time Warner Cable ( TWC), Cablevision Systems ( CVC) and DISH Network ( DISH) are likely to return 13%, 9%, 3% and 4%, respectively.

The stock received 71% buy ratings from 10 of the 14 analysts covering it, while 4 rated a hold.

8. Clearwire ( CLWR) provides wireless broadband services.

According to analysts polled by Bloomberg, the company will likely report loss of 54 cents per share in 2011 first quarter, against losses of 48 cents and 53 cents per share in the year-ago and quarter-ago periods, respectively. Loss per share for 2011 is pegged at $1.84 and at $1.51 for 2012, compared to 2010 loss per share of $2.19.

Over the next 12 months, analysts at Bloomberg foresee the stock gaining an average 60%, while Verizon ( VZ), Sprint Nextel ( S), MetroPCS Communications ( PCS) and United States Cellular ( USM) are likely to return 3%, 17%, 2% and -11%, respectively.

Of the 20 analysts covering Clearwire, 7 recommend a buy, 12 rate a hold and 1 suggests selling.

7. Dendreon ( DNDN) is a biotechnology company involved in discovering and developing immunology based therapeutic products to fight cancer.

The company reported loss of 64 cents per share for 2010 fourth quarter against 28 cents and 56 cents loss per share in the year-ago and quarter-ago periods, respectively. Loss per share for 2011 is pegged at $2.23, in comparison to loss of $3.18 per share for 2010. The company is anticipated to turn profitable in 2012 with earnings per share of 68 cents.

Of the 21 analysts covering the stock, 14 recommend buying, 5 suggest holding and 2 rate selling, representing 67% buy ratings. In comparison, MannKind ( MNKD) and Agenus ( AGEN) have buy ratings of 17% and 0%, respectively.

The stock has 61% upside over the next 12 months with a consensus target price of $52.7, according to analysts polled by Bloomberg.

6. US Airways Group ( LCC) operates an air carrier network that transports passengers, freight and mail.

The company reported earnings of 17 cents per share for 2010 fourth quarter, in comparison to loss of 49 cents per share and earnings of $1.22 per share in the year-ago and quarter-ago periods, respectively. Earnings per share are pegged at $2.24 for 2011 and $2.44 for 2012.

At $8.36, the stock trades at an attractive PE multiple of 4.9, whereas Delta Air Lines ( DAL), AMR Corporation ( AMR), Jet Blue Airways ( JBLU), and Southwest Airlines ( LUV) are trading at PE multiples of 10.3, 6.4, 5.6 and 11.8, respectively.

The stock is expected to gain an average 61% over the next 12 months, as per analysts polled by Bloomberg. Of the 13 analysts covering US Airways, 7 recommend buying, and 6 rate holding.

5. Nektar Therapeutics ( NKTR) is a clinical-stage biopharmaceutical major.

The company reported a loss of 24 cents per share for 2010 fourth quarter against a loss of 8 cents and 9 cents per share in the year-ago and quarter-ago periods, respectively. Loss per share is pegged at $1.31 for 2011 and $1.16 cents for 2012.

The stock has a 73% upside over the next 12 months with a consensus target price of $15.4, analysts polled by Bloomberg forecast. In comparison, pharma giants Johnson & Johnson ( JNJ), Pfizer ( PFE), Merck ( MRK), Abbott Laboratories ( ABT), Bristol Myers Squibb ( BMY) and Eli Lilly ( LLY) have upsides of 1%-16%.

Of the 11 analysts covering the stock, 8 recommend buying and 3 suggest holding, representing 73% buy ratings.

4. Assured Guaranty ( AGO) provides financial guaranty insurance and reinsurance, as well as mortgage guaranty coverage.

Data from Bloomberg has analysts predicting earnings of 84 cents per share in 2011 first quarter as against earnings of $1.69 and loss of 86 cents per share in the year-ago and quarter-ago periods, respectively. Earnings per share are pegged at $3.59 for 2011 and $3.27 for 2012.

The stock's return-on-equity was 15.0% during the past 12 months, whereas MBIA ( MBI), PMI Group ( PMI), XL Group ( XL) and Old Republic International ( ORI) had ROEs of 1.9%, -135.3%, 7.1% and 0.7%, respectively.

Data from Bloomberg has analysts predicting an average 12-month target price of $24.8, up 77% from the current level. Of the eight analysts covering Assured Guaranty, five recommend buying and three suggest holding.

The stock is currently trading at an attractive forward PE multiple of 3.96 and EV-to-EBITDA ratio of 5.2.

3. China Ming Yang Wind Power Group ( MY) designs, manufactures, sells and services megawatt-class wind turbines.

The stock gained around 1.6% in the past one month, while Broadwind Energy ( BWEN) and Wuhan General Group China ( WUHN) had downsides of -21.9% and -0.9%, respectively.

On an optimistic note, all five analysts covering the stock, recommend buying. The stock has 83% upside over the next 12 months with a consensus target price of $17.5, analysts polled by Bloomberg envisage.

2. Nalco Holding ( NLC) provides integrated water treatment and process improvement services.

Analysts polled by Bloomberg foresee the company reporting earnings of 31 cents per share in 2011 first quarter as against earnings per share of 18 cents and 40 cents in the year-ago and quarter-ago periods, respectively. Earnings per share are pegged at $1.70 for 2011 and $2.04 for 2012, up from $1.41 per share reported for 2010.

The stock's return-on-equity was 33.6% during the past 12 months, whereas Danaher ( DHR), Ecolab ( ECL), Ashland ( ASH) and Arch Chemicals ( ARJ) had ROEs of 14.1%, 25.7%, 9.0% and 16.7%, respectively.

Data from Bloomberg has analysts predicting an average 12-month target price of $51.5, up 92% from the current level. Of the 19 analysts covering the stock, 8 recommend buying, while 7 suggest holding and 4 rate selling.

1. Central European Distribution ( CEDC) produces and distributes branded vodka in Central and Eastern Europe.

Analysts polled by Bloomberg expect the company to report earnings per share of $1.95 for 2011 and $2.10 for 2012, a significant turnaround from loss of $1.32 per share reported for 2010.

At $13.94, the stock is trading at an attractive PE multiple of 8.5, whereas Anheuser-Busch ( BUD), Cia de Bebidas das Americas(Ambev) ( ABV), Constellation Brands ( STZ) and Moslon Coors Brewing ( TAP) are trading at PE multiples of 57.8, 28.2, 20.0 and 44.6, respectively.

The stock received 59% buy ratings from 10 of the 17 analysts covering the stock, while 6 rated a hold and one suggests selling.

Data from Bloomberg has analysts forecasting an average price target of $27.8, up 99% from current levels.

>To see these stocks in action, visit the 10 Mid-Caps With Upside portfolio on Stockpickr.

If you liked this article you might like

China Real Estate Information Corporation Stock Downgraded (CRIC)

China Real Estate Information Corporation Stock Downgraded (CRIC)

3 Stocks That Will Lead Next China Rally

3 Stocks That Will Lead Next China Rally

China Real Estate Information Corporation Stock Upgraded (CRIC)

China Real Estate Information Corporation Stock Upgraded (CRIC)

China Real Estate Information Corporation Stock Downgraded By TheStreet Ratings (CRIC)

China Real Estate Information Corporation Stock Downgraded By TheStreet Ratings (CRIC)

Don Dion's Weekly ETF Winners and Losers

Don Dion's Weekly ETF Winners and Losers